Mono Pharmacare Limited Valuation

MONOPHARMA · Healthcare · Current price ₹8.9

Full stock page
DocStoX fair value
Not published yet
No estimate for MONOPHARMA at this time
Current price
₹9
P/E ratio
44.5x
P/B ratio
0.5x
Model it yourself — Earnings Yield Calculator
Opens pre-filled with Mono Pharmacare Limited's latest numbers.

Is Mono Pharmacare Limited undervalued?

We have not published a fair value estimate for Mono Pharmacare Limited yet. Our valuation engine covers the market in waves, and this company has not been through a run that met our publishing bar. Rather than show a second, inconsistent number here, we would rather show none. The ratios, peer comparison and methodology below are still based on Mono Pharmacare Limited's reported financials.

Valuation multiples

Mono Pharmacare Limited trades at a P/E of 44.5x and a P/B of 0.5x, with a dividend yield of 0.0%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.

How we estimate fair value

When we publish an estimate for Mono Pharmacare Limited, it will appear here with the full working: the models used and their weights, every assumption and its source, the confidence band, and what data was missing. That is the same methodology we apply to every company.

Read the full fair-value methodology

Understand the ratios

P/E RatioP/B RatioPEG RatioEarnings Yield

More on Mono Pharmacare Limited

Fair ValueIntrinsic ValueDCFFinancial RatiosPeers

DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.